Q-omics provides the consensus-scored SCYGR2 profile across patient tissues and cancer cell-line models. Additionally, SCYGR2 RNA expression shows 556 significant protein co-abundance associations, with the highest sampling consensus in LSCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SCYGR2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SCYGR2 in patient tissues and cancer cell lines. In patient samples, SCYGR2 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set. In cancer cell lines, SCYGR2 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_NSCLC_LUAD.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	556	LSCC (191)	view →
Function (mass-spec)	83	LUAD (53)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	665	LUNG_NSCLC_LUAD (344)	view →
shRNA	149	LUNG_NSCLC_LUAD (146)	view →